MGMT and glioblastoma: While the O-6-methylguanine-DNA methyltransferase promoter methylation status, strongly associated with prolonged survival in TMZ-treated GBM patients [8–10, 34], was not analyzed in our study, the existing literature suggests that its status remains age-independent and stable [35].